Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATO Study: UC-MSCs in Ischemic Cardiomyopathy
NCT06145035Phase 2Recruiting
- Start
- Mar 2024
- Primary completion
- Jan 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy (ICM). Started Mar 2024; status: recruiting.
02
Drugs
umbilical cord-derived mesenchymal stromal cells
03
Conditions
ischemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NCT06145035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06145035.